Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Onyx Biotec IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Onyx Biotec IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
For the Onyx Biotec IPO, the company is issuing shares at a pre-issue EPS of ₹2.54 and a post-issue EPS of ₹1.67. The pre-issue P/E ratio is 24.01x, while the post-issue P/E ratio is 36.52x against the Industry P/E ratio is 75.10x. The company's ROCE for FY24 is 10.58% and RoE for FY24 is 12.19%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹2.54 |
| EPS Post IPO (Rs.) | ₹1.67 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 24.01 |
| P/E Post IPO | 36.52 |
| Adjusted 12M P/E Post IPO | |
| ROE | 12.19% |
| ROCE | 10.58% |
| P/BV | 1.99 |
| Debt/Equity | 1.24 |
| RoNW | 12.19% |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
